Inventor · disambiguated record
Yong Wang
Also filed as: WANG YONG · WANG YONG-YAO
18 granted patents·18 pending applications·11 citations·filing 2006–2024
88Inventor score
Files withNANJING SANHOME PHARMACEUTICAL CO LTD13CAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES3CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD2NANJING SANHOME PHARMACEUTICAL2SHANDONG XINCHUANG BIOTECHNOLOGY CO LTD2
Top patents by PatentIndex Score
36 records- 0191US11098282B1Serum-free culture medium for in vitro maturation of bovine oocytes and a method for culture of oocytesUNIV NORTHWEST A&F·Filed 2020·Granted Aug 24, 2021·5 cites·7 claims
- 0282US11186587B2Compound as ACC inhibitor and use thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2018·Granted Nov 30, 2021·3 cites·8 claims
- 0377US11993596B2Fused tri-cyclic compound as PDE3/PDE4 dual inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted May 28, 2024·1 cites·21 claims
- 0473US2024294526A1Fused tri-cyclic compound as a pde3/pde4 dual inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2024·Application pending·0 cites
- 0571US9255107B2Heteroaryl alkyne compound and use thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2013·Granted Feb 9, 2016·1 cites·18 claims
- 0662US10077258B2Substituted pyrimidine compounds as phosphatidylinositol 3-kinase delta inhibitor and use thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2016·Granted Sep 18, 2018·1 cites·17 claims
- 0759US11559606B2Semi-synthetic tissue constructs for tissue regenerationPENN STATE RES FOUND·Filed 2017·Granted Jan 24, 2023·0 cites·19 claims
- 0858US12448610B2Preparation of glycosyltransferase UGT76G1 mutant and use thereofCAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES·Filed 2020·Granted Oct 21, 2025·0 cites·12 claims
- 0956US8530507B2Use of levo-ornidazole in the preparation of anti-anaerobic bacteria infection drugsWANG YONG·Filed 2006·Granted Sep 10, 2013·0 cites·5 claims
- 1055US2022049235A1Engineering Bacteria for Ferulic Acid Production, Preparation Method and Use ThereofCAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES·Filed 2021·Application pending·0 cites
- 1153US2021317109A1Tricyclic substituted piperidine dione compoundMEDSHINE DISCOVERY INC·Filed 2019·Application pending·0 cites
- 1252US11375718B2Use of prodigiosin in resisting potyvirusTOBACCO RES INST OF CHI ACAD OF AGR SCI·Filed 2020·Granted Jul 5, 2022·0 cites·5 claims
- 1352US2021395235A1COMPOUND AS TGF-beta R1 INHIBITOR AND APPLICATION THEREOFNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1452US2025234784A1Photodetector based on transverse dember effect and preparation method thereofHEATEX SENSING TECH HUZHOU CO LTD·Filed 2024·Application pending·0 cites
- 1552US2024131086A1Use of clostridium ghonii combined with tumor angiogenesis inhibitorSHIHUIDA PHARMACEUTICAL GROUP JILIN CO LTD·Filed 2022·Application pending·0 cites
- 1651US2022332829A1Anti-b7-h3 antibody and application thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1750US12473280B2Substituted tricyclic compound as PRMT5 inhibitor and use thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2020·Granted Nov 18, 2025·0 cites·11 claims
- 1850US10947179B22-(3,4-dihydroxyphenyl)ethyl 3-hydroxybutanoate, composition, and method for improving function of aortic endothelial cellUNIV XI AN JIAOTONG·Filed 2019·Granted Mar 16, 2021·0 cites·7 claims
- 1949US2024115627A1Use of clostridium ghonii spore combined with pembrolizumabSHANDONG XINCHUANG BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 2049US2020399587A1Culture medium for improving development of bovine in vitro fertilized embryos and cloned embryosNORTHEAST A&F UNIV·Filed 2020·Application pending·0 cites
- 2148US2022235335A1Glycosyltransferase Mutant and Use ThereforCAS CENTER FOR EXCELLENCE IN MOLECULAR PLANT SCIENCES·Filed 2020·Application pending·0 cites
- 2247US11987627B2Anti-CD47 antibody and application thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2019·Granted May 21, 2024·0 cites·8 claims
- 2347US2021078932A13,4-dihydroxyphenethyl 3-hydroxybutanoate, preparation and use thereofUNIV XI AN JIAOTONG·Filed 2020·Application pending·0 cites
- 2447US2022395799A1Biochip, method of preparation and use thereofBIG SHENZHEN·Filed 2019·Application pending·0 cites
- 2546US2013202698A1L-ornidazole formulations and their applications in treatment of parasitic infectionsNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 2644US9139574B2Tumor targeted drug combretastatin A4 derivativeWANG YONG·Filed 2012·Granted Sep 22, 2015·0 cites·11 claims
- 2744US2022002288A1Monobactam compounds and use thereforNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 2842US2021292279A1Method for preparing coagulation factor xia inhibitor and intermediate thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
- 2941US9512108B29,9,10,10-Tetrafluoro-9,10-dihydrophenanthrene hepatitis C virus inhibitor and application thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2014·Granted Dec 6, 2016·0 cites·19 claims
- 3041US2015152088A1Alkynyl heteroaromatic compound and use thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 3139US2008177083A1Use of Levo-Ornidazole For Preparing Anti-Parasitic Infection DrugNANJING SANHOME PHARMACEUTICAL·Filed 2006·Application pending·0 cites
- 3239US2010204324A1Optically Active N-(Alpha-Mercaptopropionyl)GlycineNANJING SANHOME PHARMACEUTICAL·Filed 2007·Application pending·0 cites
- 3337US9963480B2Nucleoside phosphoramidate compound and use thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2014·Granted May 8, 2018·0 cites·18 claims
- 3435US10961222B2Chemical compound of isocitrate dehydrogenase inhibitor, and application thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2017·Granted Mar 30, 2021·0 cites·10 claims
- 3528US10920229B2Method for improving heterologous synthesis of Escherichia coli into polyketides and use of sameSHANGHAI INST BIOLOGICAL SCIENCES CAS·Filed 2015·Granted Feb 16, 2021·0 cites·10 claims
- 3623US10314809B2Application of derivative of clostridium ghoniiSHANDONG XINCHUANG BIOTECHNOLOGY CO LTD·Filed 2015·Granted Jun 11, 2019·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Yong Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →